Latest News
Select the category
Scancell to present three posters at the Seventh International Cancer Immunotherapy Conference
Scancell Appoints Dr Mandeep Sehmi as Head of Business Development
Scancell Appoints Sath Nirmalananthan as Chief Financial Officer
What do cancer-specific T cells ‘see’?
Modi-1 trial open for expansion in combination with checkpoint inhibitors
Extension of exercise period for CEO share options
Pipeline strategy and business update
Annual Meeting of the American Society of Clinical Oncology (ASCO), 2 – 6 June 2023 in Chicago, Illinois, USA
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting
SARS-Cov-2 Spike RBD and Nucleocapsid Encoding DNA Vaccine Elicits T cell and Neutralising Antibody Responses that Cross React with Variants
Annual Report 30th April 2023
Issue of share options to Non-Executive Directors
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
